Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Edwin E Reyes
David J VanderWeele
Masis Isikbay
Ryan Duggan
Alexa Campanile
Walter M Stadler
Donald J Vander Griend
Russell Z Szmulewitz
机构：
[1] University of Chicago,Department of Surgery
[2] University of Chicago,Committee on Immunology
[3] University of Chicago,Department of Medicine
[4] University of Chicago,Flow Cytometry Facility
来源：
Journal of Translational Medicine | / 12卷
关键词：
Prostate neoplasms; Androgen receptor; Circulating tumor cells; Castration-resistant prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
    Pak, Sahyun
    Suh, Jungyo
    Park, Seo Young
    Kim, Yunlim
    Cho, Yong Mee
    Ahn, Hanjong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells
    Capoun, Otakar
    Mikulova, Veronika
    Jancikova, Marketa
    Honova, Hana
    Kolostova, Katarina
    Sobotka, Roman
    Michael, Pesl
    Zima, Tomas
    Hanus, Tomas
    Soukup, Viktor
    ANTICANCER RESEARCH, 2016, 36 (04) : 2019 - 2026
  • [33] Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
    Graham, Laura
    Schweizer, Michael T.
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [34] Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
    Obinata, Daisuke
    Lawrence, Mitchell G.
    Takayama, Kenichi
    Choo, Nicholas
    Risbridger, Gail P.
    Takahashi, Satoru
    Inoue, Satoshi
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [35] Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-resistant Prostate Cancer
    Okegawa, Takatsugu
    Itaya, Naoshi
    Hara, Hidehiko
    Tambo, Mitsuhiro
    Nutahara, Kikuo
    ANTICANCER RESEARCH, 2014, 34 (11) : 6705 - 6710
  • [36] Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
    Laura Graham
    Michael T. Schweizer
    Medical Oncology, 2016, 33
  • [37] Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
    Cattrini, Carlo
    Rubagotti, Alessandra
    Zinoli, Linda
    Cerbone, Luigi
    Zanardi, Elisa
    Capaia, Matteo
    Barboro, Paola
    Boccardo, Francesco
    CANCERS, 2019, 11 (09)
  • [38] Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
    Chen, Qiao-Hong
    Munoz, Erick
    Ashong, Dennis
    CANCERS, 2024, 16 (03)
  • [39] Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
    Lozano, Rebeca
    Lorente, David
    Aragon, Isabel M.
    Romero-Laorden, Nuria
    Nombela, Paz
    Mateo, Joaquim
    Reid, Alison H. M.
    Cendon, Ylenia
    Bianchini, Diletta
    Llacer, Casilda
    Sandhu, Shahneen K.
    Sharp, Adam
    Rescigno, Pasquale
    Garces, Teresa
    Pacheco, Maria I.
    Flohr, Penelope
    Massard, Christophe
    Lopez-Casas, Pedro P.
    Castro, Elena
    de Bono, Johann S.
    Olmos, David
    CANCERS, 2021, 13 (10)
  • [40] Genistein resists castration-resistant prostate cancer by inhibiting the androgen receptor pathway
    Yu, Xiao-Ping
    Zheng, Lu-Jie
    Yan, Jia-Li
    Luo, Yan
    Song, Xiao-Long
    Fu, Tian-Yu
    Peng, Xiao-Li
    Du, Jing-Chang
    Han, Bin
    Li, Fei
    Zhu, Yan-Feng
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2025,
12345